Apobec 3G Efficiently Reduces Infectivity of the Human Exogenous Gammaretrovirus XMRV

Kristin Stieler, Nicole Fischer · 2010

Read Apobec 3G Efficiently Reduces Infectivity of the Human Exogenous Gammaretrovirus XMRV by Kristin Stieler, Nicole Fischer (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0011738.txt.

Description

Kristin Stieler and Nicole Fischer tested a human defence protein against the retrovirus XMRV, in PLOS ONE in 2010. At the time, XMRV was thought to play a part in two human illnesses, prostate cancer and chronic fatigue syndrome. Beyond those disease links, its tissue targets and its response to the body's anti-retroviral factors needed study.

The authors showed the protein APOBEC3G sharply cuts the virus's power to infect new cells. That result adds XMRV to the list of retroviruses this defender can blunt. It also sharpens a tool for studying how such factors might be used against retroviral infection more broadly.

Catalog record

CREATORKristin Stieler, Nicole Fischer
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE42 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0011738

Browse the full library · About the Tower of Babel